Final results from a national multicenter phase II trial of combination bacillus Calmette-Guérin plus interferon α-2B for reducing recurrence of superficial bladder cancer☆
2006 ◽
Vol 24
(4)
◽
pp. 344-348
◽
Keyword(s):
Phase Ii
◽
2004 ◽
Vol 22
(14_suppl)
◽
pp. 4716-4716
2004 ◽
Vol 22
(14_suppl)
◽
pp. 4716-4716
2013 ◽
Vol 190
(3)
◽
pp. 857-862
◽
2015 ◽
Vol 33
(1)
◽
pp. 46-47